Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
107.28
+2.01 (+1.91%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
34
35
Next >
How Is The Market Feeling About Abbott Laboratories?
August 10, 2023
Via
Benzinga
Is Abbott Laboratories Stock a Buy Now?
August 10, 2023
The healthcare company recently boosted its guidance.
Via
The Motley Fool
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
Find out if AbbVie can overcome sinking sales of its top-selling product.
Via
The Motley Fool
2 Top Stocks to Buy in August and Hold Forever
August 06, 2023
These companies won't disappoint long-term investors.
Via
The Motley Fool
This Is What Whales Are Betting On Abbott Laboratories
August 04, 2023
Via
Benzinga
Does Abbott Laboratories' Dividend Make It a Buy?
August 04, 2023
There's a lot to like about this business when it comes to dividends.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
July 31, 2023
Via
Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
July 25, 2023
Via
Benzinga
Looking At Abbott Laboratories's Recent Unusual Options Activity
July 20, 2023
Via
Benzinga
Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript
July 20, 2023
ABT earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher
July 31, 2023
Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans.
Via
MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
July 28, 2023
Via
Benzinga
Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook
July 27, 2023
Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance.
Via
Investor's Business Daily
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform – Insights From The Discussion
July 27, 2023
Chronic back pain is a significant issue in the United States, affecting millions of individuals annually.
Via
Benzinga
Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism
July 26, 2023
Abbott Laboratories (NYSE: ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased
Via
Benzinga
Abbott Stock Edges Higher As Earnings Decline But Still Top Forecasts
July 20, 2023
The company continues to expect some Covid sales this year, but cut its outlook.
Via
Investor's Business Daily
2 Top Dividend Stocks to Buy and Hold Forever
July 25, 2023
They have been paying dividends for a long time.
Via
The Motley Fool
Russia Is Seizing European Company Assets — What US Businesses Are Still At Risk?
July 24, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
July 24, 2023
Via
Benzinga
3 Ultrareliable Dividend Stocks to Buy and Hold for Decades
July 24, 2023
These stocks have decades of annual dividend raises under their belts, and rising healthcare costs mean there could be plenty more to come.
Via
The Motley Fool
Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday
July 24, 2023
Citigroup raised the price target for Cintas Corporation (NASDAQ: CTAS) from $540 to $550. Citigroup analyst Leo Carrington downgraded the stock from Buy to Neutral. Cintas shares fell 0.8% to $503.43...
Via
Benzinga
Abbott's Higher Than Expected Q2 Earnings: Analyst Foresees Strong Performance In 2024
July 21, 2023
Thursday, Abbott Laboratories (NYSE: ABT) reported better-than-expected Q2 earnings.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
July 21, 2023
Via
Benzinga
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review
July 21, 2023
But all the major indexes are at or near 15-month highs.
Via
Investor's Business Daily
J&J, Abbott Labs And JPM Among Jim Cramer's Top Picks As Market Shifts Focus From Tech
July 21, 2023
Via
Benzinga
Johnson & Johnson's Inflection Point: What it Means for Investors
July 20, 2023
Johnson & Johnson stock and the company show signs of strength and growth while offering value and yield relative to its peer Abbott Laboratories.
Via
MarketBeat
Exposures
COVID-19
Abbott Laboratories Has the Prescription for Higher Share Prices
July 20, 2023
Abbott Laboratories stock is ready to rebound after a year of correction. The decline of COVID is priced into the market, and organic growth is accelerating.
Via
MarketBeat
Exposures
COVID-19
Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories
July 20, 2023
Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues
Via
Benzinga
Abbott Laboratories Clocks Strong Q2 Growth In Underlying Base Business, Reaffirms FY23 Outlook
July 20, 2023
Abbott Laboratories (NYSE: ABT) has reported Q2 FY23 adjusted EPS of $1.08, down 25% Y/Y, beating the consensus of $1.05.
Via
Benzinga
Earnings Scheduled For July 20, 2023
July 20, 2023
Companies Reporting Before The Bell • Taiwan Semiconductor (NYSE:TSM) is estimated to report quarterly earnings at $1.08 per share on revenue of $15.49 billion.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
34
35
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.